BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 35067905)

  • 1. SARS-CoV-2 infection in dialysis and kidney transplant patients: immunological and serological response.
    Alberici F; Affatato S; Moratto D; Mescia F; Delbarba E; Guerini A; Tedesco M; Burbelo PD; Zani R; Castagna I; Gallico A; Tonoli M; Venturini M; Roccaro AM; Giacomelli M; Cohen JI; Giustini V; Dobbs K; Su HC; Fiorini C; Quaresima V; Viola FB; Vizzardi V; Gaggiotti M; Bossini N; Gaggia P; Badolato R; Notarangelo LD; Chiarini M; Scolari F
    J Nephrol; 2022 Apr; 35(3):745-759. PubMed ID: 35067905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct Expression Patterns of Interleukin-22 Receptor 1 on Blood Hematopoietic Cells in SARS-CoV-2 Infection.
    Albayrak N; Orte Cano C; Karimi S; Dogahe D; Van Praet A; Godefroid A; Del Marmol V; Grimaldi D; Bondue B; Van Vooren JP; Mascart F; Corbière V
    Front Immunol; 2022; 13():769839. PubMed ID: 35422799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenicity of SARS-CoV-2 mRNA vaccine in dialysis and kidney transplant patients: A systematic review.
    Akyol M; Çevik E; Ucku D; Tanrıöver C; Afşar B; Kanbay A; Covic A; Ortiz A; Basile C; Kanbay M
    Tuberk Toraks; 2021 Dec; 69(4):547-560. PubMed ID: 34957748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence of potent humoral immune activity in COVID-19-infected kidney transplant recipients.
    Hartzell S; Bin S; Benedetti C; Haverly M; Gallon L; Zaza G; Riella LV; Menon MC; Florman S; Rahman AH; Leech JM; Heeger PS; Cravedi P
    Am J Transplant; 2020 Nov; 20(11):3149-3161. PubMed ID: 32786152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Humoral Immune Response to BNT162b2 Vaccine Is Associated With Circulating CD19+ B Lymphocytes and the Naïve CD45RA to Memory CD45RO CD4+ T Helper Cells Ratio in Hemodialysis Patients and Kidney Transplant Recipients.
    Duni A; Markopoulos GS; Mallioras I; Pappas H; Pappas E; Koutlas V; Tzalavra E; Baxevanos G; Priska S; Gartzonika K; Mitsis M; Dounousi E
    Front Immunol; 2021; 12():760249. PubMed ID: 34925330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term efficacy and safety of SARS-CoV-2 vaccination in patients with chronic kidney disease, on dialysis or after kidney transplantation: a national prospective observational cohort study.
    Bouwmans P; Messchendorp AL; Sanders JS; Hilbrands L; Reinders MEJ; Vart P; Bemelman FJ; Abrahams AC; van den Dorpel MA; Ten Dam MA; de Vries APJ; Rispens T; Steenhuis M; Gansevoort RT; Hemmelder MH;
    BMC Nephrol; 2022 Feb; 23(1):55. PubMed ID: 35123437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-COV-2 vaccine responses in renal patient populations.
    Smith RM; Cooper DJ; Doffinger R; Stacey H; Al-Mohammad A; Goodfellow I; Baker S; Lear S; Hosmilo M; Pritchard N; Torpey N; Jayne D; Yiu V; Chalisey A; Lee J; Vilnar E; Cheung CK; Jones RB
    BMC Nephrol; 2022 May; 23(1):199. PubMed ID: 35641961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune Cells Profiles In The Peripheral Blood Of Patients With Moderate To Severe COVID-19 And Healthy Subjects With and Without Vaccination With The Pfizer-BioNTech mRNA Vaccine.
    Al-Attiyah R; Safar HA; Botras L; Botras M; Al-Kandari F; Chehadeh W; Mustafa AS
    Front Immunol; 2022; 13():851765. PubMed ID: 35898494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of tozinameran (BNT162b2) mRNA vaccine on kidney transplant and chronic dialysis patients: 3-5 months follow-up.
    Ben-Dov IZ; Oster Y; Tzukert K; Alster T; Bader R; Israeli R; Asayag H; Aharon M; Burstein I; Pri-Chen H; Imam A; Abel R; Mor-Yosef Levi I; Khalaileh A; Oiknine-Djian E; Bloch A; Wolf DG; Dranitzki Elhalel M
    J Nephrol; 2022 Jan; 35(1):153-164. PubMed ID: 34988942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between COVID-19 and HLA in kidney transplant recipients, an evaluation of predictive and prognostic factors.
    Ertosun MG; Özkan Ö; Darbaş Ş; Özel D; Bilge U; Sayin Ekinci N; Yilmaz VT; Uçar F; Koçak H; Özkan Ö
    Clin Transplant; 2022 Feb; 36(2):e14525. PubMed ID: 34726292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increasing SARS-CoV-2 seroprevalence among UK pediatric patients on dialysis and kidney transplantation between January 2020 and August 2021.
    Bamber HN; Kim JJ; Reynolds BC; Afzaal J; Lunn AJ; Tighe PJ; Irving WL; Tarr AW
    Pediatr Nephrol; 2023 Nov; 38(11):3745-3755. PubMed ID: 37261514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodialysis-Associated Immune Dysregulation in SARS-CoV-2-Infected End-Stage Renal Disease Patients.
    González-Cuadrado C; Caro-Espada PJ; Chivite-Lacaba M; Utrero-Rico A; Lozano-Yuste C; Gutierrez-Solis E; Morales E; Sandino-Pérez J; Gil-Etayo FJ; Allende-Martínez L; Laguna-Goya R; Paz-Artal E
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in Humoral and Cellular Vaccine Responses to SARS-CoV-2 in Kidney and Liver Transplant Recipients.
    Furian L; Russo FP; Zaza G; Burra P; Hartzell S; Bizzaro D; Di Bello M; Di Bella C; Nuzzolese E; Agnolon C; Florman S; Rana M; Lee JH; Kim Y; Maggiore U; Maltzman JS; Cravedi P
    Front Immunol; 2022; 13():853682. PubMed ID: 35493446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of the COVID-19 Pandemic on Kidney Transplant and on Chronic Dialysis Patients.
    Amsei TQM; Gorayeb-Polacchini FS; Caldas HC; Fernandes-Charpiot IMM; Ferreira-Baptista MAS; Abbud-Filho M
    Transplant Proc; 2022 Jun; 54(5):1282-1285. PubMed ID: 35589414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Multicenter Cohort Study of Indian Centers on Reoccurring SARS-CoV-2 Infections in Kidney Transplant Recipients.
    Kute VB; Hegde U; Das P; Sharma A; Bahadur MM; Sil K; Guleria S; Varma PP; Jamale T; Meshram HS
    Exp Clin Transplant; 2021 Oct; 19(10):1023-1031. PubMed ID: 34498549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Humoral response to SARS-CoV-2 infection among liver transplant recipients.
    Becchetti C; Broekhoven AGC; Dahlqvist G; Fraga M; Zambelli MF; Ciccarelli O; Saouli AC; Trizzino A; Banz V; Dufour JF; Roukens AHE; Torres Morales SP; Myeni SK; Kikkert M; Feltkamp MCW; Coenraad MJ
    Gut; 2022 Apr; 71(4):746-756. PubMed ID: 34987065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kidney transplant rejection rate in screened patients for anti-SARS-CoV-2 antibodies, during COVID-19 pandemic in Northern Italy.
    Asti AL; Lilleri D; Gregorini M; Zelini P; Pattonieri EF; Sepe V; Libetta C; Islami T; Baldanti F; Rampino T
    New Microbiol; 2021 Jul; 44(3):184-186. PubMed ID: 34783351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of natural immunity to SARS-CoV-2 over time in wait-listed dialysis patients and recent kidney transplant recipients.
    Lubetzky M; Zhao Z; Sukhu A; Sharma V; Sultan S; Kapur Z; Albakry S; Craig-Schapiro R; Lee JR; Salinas T; Aull M; Kapur S; Cushing M; Dadhania DM
    Nephrol Dial Transplant; 2022 Jul; 37(8):1585-1587. PubMed ID: 35323982
    [No Abstract]   [Full Text] [Related]  

  • 19. On the need to better protect hemodialysis patients: a comment on "IMPact of the COVID-19 epidemic on the moRTAlity of kidney transplant recipients and candidates in a French Nationwide registry sTudy (IMPORTANT)".
    Torreggiani M; Fessi H; Piccoli GB
    Kidney Int; 2021 Mar; 99(3):770. PubMed ID: 33444544
    [No Abstract]   [Full Text] [Related]  

  • 20. Adaptive lymphocyte profile analysis discriminates mild and severe forms of COVID-19 after solid organ transplantation.
    Del Bello A; Kamar N; Vergez F; Faguer S; Marion O; Beq A; Lathrache Y; Abravanel F; Izopet J; Treiner E
    Kidney Int; 2021 Oct; 100(4):915-927. PubMed ID: 34126110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.